Vyaire Medical said yesterday it acquired neonatal ventilation equipment developer Acutronic for an undisclosed amount, and said it inked a deal to acquire mechanical ventilation dev IMTmedical.
Both of the new acquisitions are based in Europe, with Acutronic split between Switzerland and Germany and IMTmedical based solely in Switzerland, Chicago-based Vyaire Medical said.
“The transactions we are announcing today, along with our own internal development efforts, underscore our commitment to positioning Vyaire Medical as a global respiratory care leader. Our acquisition of Acutronic and IMTmedical immediately enhance our product portfolio, expand intellectual capital and broaden our technological capabilities; all of which will accelerate Vyaire Medical’s growth. We could not be more excited about taking these amazing products, in combination with our own, to market to advance our mission of improving patient outcomes and providing increased value to our customers,” Vyaire Medical prez & CEO Dave Mowry said in a prepared statement.
Acutronic designs and manufactures neonatal ventilation equipment, Vyaire said, and is known for its ventilation products for both neonatal and pediatric intensive care units.
IMTmedical develops and manufactures ventilation equipment for acute care centers, long-term care facilities, home healthcare and emergency service and transport uses, Vyaire said.
The IMTmedical acquisition is expected to close during the second quarter, Vyaire added. Both acquisitions are expected to be complimentary to Vyaire’s existing portfolio, the company said.
“These new acquisitions are exciting steps forward for Vyaire Medical and build on the strong progress made by the company’s management over the past year and a half. We join Dave Mowry in welcoming both the Acutronic and imtmedical teams to the Vyaire family and are excited about our joint future. We look forward to our ongoing work with Vyaire Medical as it continues to grow as the leader in respiratory care,” Apax Partners partners Steven Dyson and Arthur Brothag said in a prepared statement.
Last month, Becton Dickinson (NYSE:BDX) inked a deal to divest itself of its minority stake in Vyaire, which was previously a respiratory solutions joint venture, to joint manager Apax Partners in a deal worth $435 million.
